Tejal Somvanshi
If you've seen headlines suggesting that wanting Botox means you have OCD, that is not what the NICE guidance says. The actual clinical recommendation is more specific — and more limited — than most of the coverage implies.
NICE opened a public consultation on September 17, 2026 on updated OCD and body dysmorphic disorder (BDD) guidelines, with final publication expected in February 2027. Existing NICE guidance (CG31) already recommends that healthcare professionals consider BDD in people at higher risk of the condition, and in people seeking cosmetic or dermatological procedures under specified circumstances. Where BDD is suspected or diagnosed, NICE recommends assessment by a suitably experienced mental-health professional.
That recommendation is conditional and professional-facing, not a blanket statement about cosmetic treatment patients. It does not say that wanting Botox, fillers or other cosmetic procedures is evidence of a mental-health condition. It says that clinicians should consider whether BDD is present in certain higher-risk groups.
BDD is a recognised condition in which a person becomes preoccupied with a perceived physical flaw — often one that others cannot see or consider minor — to a degree that causes significant distress or interferes with daily life. It is distinct from general dissatisfaction with appearance, and it is distinct from the decision to have a cosmetic procedure.
What the NICE guidance actually requires
The existing guidance recommends that professionals use specific assessment questions when BDD is a concern, and refer for specialist mental-health assessment where it is suspected or diagnosed. It does not require a psychological assessment for all cosmetic patients. The focus is on identifying people who may be experiencing significant distress linked to body image in a way that could affect the appropriateness of a cosmetic procedure for them specifically.
For patients considering Botox or other cosmetic treatments, the practical implication is that a clinician may ask about body image and how a patient feels about their appearance. That is not an accusation of mental illness — it is part of a clinical picture that good practice already encourages.
The current situation is that existing NICE CG31 guidance is in place, while an updated guideline is under development through the consultation that opened today. The cosmetic screening element is one component of the broader OCD and BDD clinical framework, not the purpose of the guidance as a whole.
Does wanting Botox mean you have OCD?
No. NICE guidance does not say that wanting Botox means a person has OCD. It recommends that clinicians consider possible body dysmorphic disorder in certain people seeking cosmetic or dermatological treatment, particularly those at higher risk. Suspected BDD should be assessed appropriately rather than inferred from a person's decision to seek cosmetic treatment. OCD and BDD are separate conditions, though they share some features.
The NICE guidance is available in full through the NICE website for patients who want to read the specific recommendations rather than rely on media summaries of them.
